Myositis-specific autoantibodies (MSAs) are specific to patients with IIMs. Myositis-associated autoantibodies (MAAs) can also occur in dermatomyositis but is commonly seen in overlap with another ...

It is also planning a late-stage study in lupus nephritis in a bid to match Benlysta, as well as trials in cutaneous lupus erythematosus and myositis.

With patients across the ongoing myositis, lupus and systemic sclerosis trials achieving DORIS remission in SLE, complete renal response in LN, and major TIS improvement in dermatomyositis ...